Titlebook: Spinal Cord Stimulation II; An Innovative Method Svante Horsch,Luc Claeys Conference proceedings 1995 Dr. Dietrich Steinkopff Verlag GmbH &

fetter

The volume presents such topics as: Spinal Cord Stimulation for Chronic Pain.- Management of Critical Limb Ischemia.- Spinal Cord Stimulation for Angina Pectoris.- Buerger‘s Disease.- Miscellaneous.978-3-642-72529-6978-3-642-72527-2

比目鱼

How to evaluate the results of neuromodulative procedures in pain ? motivational and environmental factors. This has led to the development of new instruments for pain assessment that take into account these various aspects. The interested reader can find an extensive overview of the different aspects of pain assessment in some recently published textbooks (3, 16).

祸害隐伏

龙虾

Central nervous mechanisms involved in neuropathic and nociceptive painwell-known is the gate-control hypothesis proposed by Melzack and Wall (1965) (7). The importance of this hypothesis has primarily been its impact in the development of pain relieving treatments such as transcutaneous electrical nervous stimulation (TENS) and spinal cord stimulation (SCS). The gate

Conquest

Spinal cord stimulation in ischemia and ischemic pain Possible mechanisms of action. The pioneer report by Cook et al. appeared in 1976 (12). The spread of the method for this indication was slow in the beginning, but after the presentation of the studies by Augustinsson, Jivegård, Galley, Jacobs and their collaborators (1, 16, 23–25) and others, the method has been adopted in mos

Laconic

Influence of cervical spinal cord stimulation on the vascular systemheral (1, 13, 14, 22, 26) and coronary (5, 9, 19, 21, 23) artery disease. Despite good short- and long-term success rates (8, 11, 27), this method still faces some skepticism and criticism, particularly in surgical circles (18). This attitude is mainly due to three major drawbacks of DCS: 1) its sup

轻打

Spinal cord stimulation for chronic intractable painmulation for pain relief (57). The feasibility of chronic neural stimulation was greatly increased when the miniaturized highly reliable solid-state electronic technology developed for cardiac pacemakers was transferred to implantable neural stimulators.

negotiable

altruism

Licentious

Prostanoids in the treatment of critical limb ischemiaeeing a number of young male patients with stages III and IV inoperable arterial occlusive disease being treated with prostaglandin E. at the University Vascular Surgery Clinic Nagoya (S. Shionoya). Continous intra-arterial therapy was carried out with a timer-controlled roller pump so that the pati